SG11201510792XA - Synthetic oligosaccharides for p. aeruginosa vaccine - Google Patents

Synthetic oligosaccharides for p. aeruginosa vaccine

Info

Publication number
SG11201510792XA
SG11201510792XA SG11201510792XA SG11201510792XA SG11201510792XA SG 11201510792X A SG11201510792X A SG 11201510792XA SG 11201510792X A SG11201510792X A SG 11201510792XA SG 11201510792X A SG11201510792X A SG 11201510792XA SG 11201510792X A SG11201510792X A SG 11201510792XA
Authority
SG
Singapore
Prior art keywords
synthetic oligosaccharides
aeruginosa vaccine
aeruginosa
vaccine
oligosaccharides
Prior art date
Application number
SG11201510792XA
Inventor
A Stewart Campbell
Obadiah J Plante
Original Assignee
Synglyco Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synglyco Pharmaceuticals Inc filed Critical Synglyco Pharmaceuticals Inc
Publication of SG11201510792XA publication Critical patent/SG11201510792XA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/104Pseudomonadales, e.g. Pseudomonas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/60Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622Single chain antibody (scFv)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/21Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pseudomonadaceae (F)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/10Detection of antigens from microorganism in sample from host

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG11201510792XA 2013-07-03 2014-07-01 Synthetic oligosaccharides for p. aeruginosa vaccine SG11201510792XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361842474P 2013-07-03 2013-07-03
PCT/US2014/045057 WO2015002954A1 (en) 2013-07-03 2014-07-01 Synthetic oligosaccharides for p. aeruginosa vaccine

Publications (1)

Publication Number Publication Date
SG11201510792XA true SG11201510792XA (en) 2016-01-28

Family

ID=52144159

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201510792XA SG11201510792XA (en) 2013-07-03 2014-07-01 Synthetic oligosaccharides for p. aeruginosa vaccine

Country Status (13)

Country Link
US (1) US20160144016A1 (en)
EP (1) EP3016685B1 (en)
JP (1) JP2016525507A (en)
KR (1) KR20160098161A (en)
CN (1) CN105517573A (en)
AU (1) AU2014284457A1 (en)
CA (1) CA2917192A1 (en)
CL (1) CL2015003792A1 (en)
HK (1) HK1217642A1 (en)
IL (1) IL243432A0 (en)
MX (1) MX2016000195A (en)
SG (1) SG11201510792XA (en)
WO (1) WO2015002954A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107249629A (en) * 2015-02-26 2017-10-13 生控基因疫苗股份有限公司 Comprising immunogenic protein and combination adjuvant and to induce the vaccine combination that T cells with antigenic specificity reacts
CN107827981B (en) * 2017-11-01 2019-10-25 深圳市国创纳米抗体技术有限公司 The nano antibody of anti Bacillus pyocyaneu Flugge exotoxin A and its application
EP4069751A4 (en) * 2019-12-04 2023-11-22 University of Montana Antibacterial carbohydrate vaccine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4693891A (en) * 1985-09-09 1987-09-15 Miles Laboratories, Inc. Vaccine for Pseudomonas aeruginosa
EP1479695B1 (en) * 2003-05-14 2010-02-17 Kenta Biotech AG Human monoclonal antibody specific for lipopolysaccharides (LPS) of serotype IATS O6 of Pseudomonas aeruginosa
CN101912609B (en) * 2009-08-20 2012-02-01 成都蓉生药业有限责任公司 Composition for preventing and controlling pseudomonas aeruginosa infection and preparation method thereof
EP2560981A2 (en) * 2010-04-23 2013-02-27 Ancora Pharmaceuticals Inc. Synthetic oligosaccharides for staphylococcus vaccine
CN101947323B (en) * 2010-07-26 2013-02-27 北京绿竹生物制药有限公司 Gram negative bacterium vaccine and preparation method thereof
WO2012082635A1 (en) * 2010-12-13 2012-06-21 Ancora Pharmaceuticals, Inc. Synthetic oligosaccharide group a streptococcus
EP2554549A1 (en) * 2011-08-02 2013-02-06 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Oligosaccharides and oligosaccharides-protein conjugates derived from clostridium difficile polysaccharide PS-I, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools
US20150152129A1 (en) * 2012-07-16 2015-06-04 Synglyco, Inc. Synthetic Oligosaccharides for P. Aeruginosa Vaccine

Also Published As

Publication number Publication date
JP2016525507A (en) 2016-08-25
EP3016685A4 (en) 2016-11-23
MX2016000195A (en) 2016-08-18
EP3016685B1 (en) 2018-01-31
CL2015003792A1 (en) 2017-01-20
EP3016685A1 (en) 2016-05-11
CA2917192A1 (en) 2015-01-08
WO2015002954A1 (en) 2015-01-08
HK1217642A1 (en) 2017-01-20
AU2014284457A1 (en) 2016-01-28
CN105517573A (en) 2016-04-20
KR20160098161A (en) 2016-08-18
IL243432A0 (en) 2016-03-31
US20160144016A1 (en) 2016-05-26

Similar Documents

Publication Publication Date Title
ZA201704297B (en) Pyrrolobenzodiazepine-antibody conjugates
PT3119885T (en) Antibody-fynomer conjugates
EP2970511A4 (en) Insulin-incretin conjugates
EP3074051A4 (en) Mers-cov vaccine
SI3329760T1 (en) Agricultural machine
EP2968381A4 (en) Sugar-linker-drug conjugates
GB201411896D0 (en) .
HK1217642A1 (en) Synthetic oligosaccharides for p. aeruginosa vaccine
EP3059468A4 (en) Shock-absorbing part
HK1211795A1 (en) Synthetic oligosaccharides for p. aeruginosa vaccine (paeruginosa)
PL2886635T3 (en) Disinfectant
AU350803S (en) Planter
PL2991890T3 (en) Agricultural machine
AU5549P (en) USCAL42202 Calibrachoa hybrid
AU5550P (en) USCAL41401 Calibrachoa hybrid
AU5329P (en) USCAL83901 Calibrachoa hybrid
AU5328P (en) USCAL08501 Calibrachoa hybrid
AU5378P (en) Suncallemon Calibrachoa hybrid
AU5377P (en) Suncalred Calibrachoa hybrid
AU4978P (en) USCAL91001 Calibrachoa hybrid
AU4979P (en) USCAL5302M Calibrachoa hybrid
GB2519519B (en) Stop
GB201409791D0 (en) .
GB201322661D0 (en) .
GB201420910D0 (en) Pyrrolobenzodiazepine-antibody conjugates